RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
Financial Analysis
| Ratio | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Returns | ||||
| Return on Equity | 135.7% | -25.6% | -23.0% | |
| Return on Assets | -22.4% | -24.9% | -21.8% | |
| Return on Inv Capital | 141.2% | -27.2% | -20.4% | |
| Liquidity | ||||
| Current Ratio | 17.14x | 35.34x | 26.17x | |
| Quick Ratio | 17.14x | 35.34x | 26.17x | |
| Cash Ratio | 7.97x | 6.48x | 2.76x | |
| Leverage | ||||
| Debt / Equity | -0.08x | 0.00x | 0.02x | |
| Equity Multiplier | -6.06x | 1.03x | 1.06x | |
| Efficiency | ||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | |
| Effective Tax Rate | -0.0% | -0.0% | -- | |
| Op CF / Net Income | 0.78x | 0.83x | 0.78x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--